We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-5.36%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.57B
AUM Growth
-$188M
Cap. Flow
-$40.2M
Cap. Flow %
-2.55%
Top 10 Hldgs %
25.73%
Holding
273
New
11
Increased
56
Reduced
164
Closed
13

Top Buys

Rank Stock Value
1
TKO icon
TKO Group
TKO
+$41.7M
2
ESTA icon
Establishment Labs
ESTA
+$6.42M
3
HROW icon
Harrow
HROW
+$4.38M
4
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$4.04M
5
EOLS icon
Evolus
EOLS
+$3.78M

Top Sells

Rank Stock Value
1
WWE
World Wrestling Entertainment
WWE
+$51.6M
2
CSW
CSW Industrials
CSW
+$8.4M
3
QLYS icon
Qualys
QLYS
+$7.98M
4
LCII icon
LCI Industries
LCII
+$7.16M
5
MSM icon
MSC Industrial Direct
MSM
+$5.66M

Sector Composition

Rank Sector Weight
1 Healthcare 27.91%
2 Technology 24.74%
3 Industrials 19.75%
4 Consumer Discretionary 7.88%
5 Communication Services 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EB
26
DELISTED
Eventbrite
EB
$16M 1.02%
1,623,425
+178,475
+12% +$1.83M
ASND icon
27
Ascendis Pharma A/S
ASND
$16.8B
$15.9M 1.01%
169,787
-3,676
-2% -$344K
MTN icon
28
Vail Resorts
MTN
$5.3B
$15.4M 0.98%
69,603
-1,513
-2% -$359K
POOL icon
29
Pool Corp
POOL
$7.5B
$15.4M 0.98%
43,305
-1,092
-2% -$397K
SUPN icon
30
Supernus Pharmaceuticals
SUPN
$2.77B
$15M 0.95%
544,468
-10,325
-2% -$314K
NBIX icon
31
Neurocrine Biosciences
NBIX
$16.6B
$14.9M 0.94%
132,213
-2,857
-2% -$301K
MMS icon
32
Maximus
MMS
$3.1B
$14.8M 0.94%
197,766
-2,966
-1% -$241K
ACAD icon
33
Acadia Pharmaceuticals
ACAD
$5.03B
$14.5M 0.92%
696,065
-190,388
-21% -$5.17M
OABI icon
34
OmniAb
OABI
$447M
$14.4M 0.92%
2,780,826
-51,550
-2% -$275K
SSTK icon
35
Shutterstock
SSTK
$219M
$13.6M 0.86%
357,639
-7,337
-2% -$329K
LMAT icon
36
LeMaitre Vascular
LMAT
$1.86B
$13.5M 0.86%
247,718
-4,700
-2% -$279K
OZK icon
37
Bank OZK
OZK
$5.61B
$13.4M 0.85%
362,563
-8,653
-2% -$351K
FOLD
38
DELISTED
Amicus Therapeutics
FOLD
$13.1M 0.83%
1,078,865
+30,202
+3% +$390K
RBA icon
39
RB Global
RBA
$17.5B
$12.6M 0.8%
202,091
-4,556
-2% -$281K
BBBY
40
Bed Bath & Beyond
BBBY
$442M
$12.6M 0.8%
876,862
-16,798
-2% -$411K
KNSA icon
41
Kiniksa Pharmaceuticals
KNSA
$5.93B
$11.3M 0.72%
650,366
-9,758
-1% -$164K
APPS icon
42
Digital Turbine
APPS
$1.74B
$11M 0.7%
1,814,927
-33,997
-2% -$303K
ITRN icon
43
Ituran Location and Control
ITRN
$1.05B
$10.1M 0.64%
338,745
-861
-0.3% -$24.1K
EOLS icon
44
Evolus
EOLS
$501M
$10.1M 0.64%
1,105,159
+421,890
+62% +$3.78M
WIX icon
45
WIX.com
WIX
$2.52B
$10M 0.64%
109,443
-2,322
-2% -$207K
UTMD icon
46
Utah Medical Products
UTMD
$225M
$9.6M 0.61%
111,634
-1,365
-1% -$126K
TRAK icon
47
ReposiTrak
TRAK
$159M
$9.59M 0.61%
1,094,433
-13,591
-1% -$125K
NXGN
48
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$9.14M 0.58%
385,274
-3,495
-0.9% -$65.8K
CEVA icon
49
CEVA Inc
CEVA
$1.08B
$9.07M 0.58%
467,771
-6,851
-1% -$159K
PRO
50
DELISTED
PROS Holdings
PRO
$8.69M 0.55%
251,114
-1,695
-0.7% -$58.6K
1
2
3 4 5

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q3 2023 Portfolio in Review

As of Q3 2023, Rice Hall James & Associates held 273 positions worth $1.57B, down 11% from $1.76B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Rice Hall James & Associates's Q3 2023 filing shows 11 new, 56 increased, 164 reduced and 13 closed positions. Its largest new stake was TKO Group: 449,630 shares worth $37.8M. The largest sale was World Wrestling Entertainment, an estimated $51.6M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q3 2023 buy was TKO Group: 449,630 shares worth $37.8M.
  • Rice Hall James & Associates added most to Establishment Labs in Q3 2023, an estimated $6.42M increase.
  • Rice Hall James & Associates's biggest Q3 2023 reduction was Qualys, cutting an estimated $7.98M.
  • Rice Hall James & Associates fully exited World Wrestling Entertainment in Q3 2023, selling an estimated $51.6M.
  • Rice Hall James & Associates's ten largest holdings make up 26% of its $1.57B portfolio in Q3 2023.
  • Rice Hall James & Associates opened 11 new positions and closed 13 in Q3 2023.
  • Rice Hall James & Associates's portfolio value fell 11% quarter-over-quarter to $1.57B.

Based on Rice Hall James & Associates's 13F filing for Q3 2023, filed 2 Nov 2023.